Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gallé Birgit |

Präsentationen bei wissenschaftlichen und nicht-wissenschaftlichen Veranstaltungen

Balihodzic, A; Fernandez Hernandez, FJ; Jäger, V; Vosberg, S; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer.
Proceedings of the Annual Meeting of the Austrian Society of Haematology and Medical Oncology. 2023; 16: 1-28.-OeGHO- & AHOP-Frühjahrstagung 2023; März 30-April 1, 2023; Innsbruck, AUSTRIA. [Oral Communication]
FullText

 

Balihodzic, A; Fernandez-Hernandez, FJ; Jäger, V; Vosberg, S; Tonietto, M; Schnur, T; Kainz, G; Gallé, B; Schweintzger, N; Kühberger, S; Heitzer, E; Reinisch, A; Jost, PJ; Pichler, M; Dengler, MA Application of genome-wide CRISPR/Cas9 screen to identify synthetic lethality with MCL-1 inhibition in lung cancer
Doctoral Day of Medical University of Graz; FEB 9, 2023; Graz, AUSTRIA. 2023. [Poster]

 

Reinisch, I; Galle, B; Klymiuk, I; Karbiener, M; Galhuber, M; Krstic, J; Prokesch, A p53-DRIVEN miRNA-92a EXPRESSION AS POTENTIAL REGULATOR OF BAT ACTIVITY UNDER FASTING.
42nd Scientific meeting of the ELC. 2019; -42nd Annual Scientific Meeting of the European Lipoprotein Club; SEP 9-12; Tutzing, GERMANY. [Oral Communication]

 

Reinisch, I; Galle, B; Klymiuk, I; Karbiener, M; Galhuber, M; Krstic, J; Prokesch, A. p53-DRIVEN miRNA-92a EXPRESSION AS POTENTIAL REGULATOR OF BAT ACTIVITY UNDER FASTING
DocDay 2019; NOV 19 2019; Graz, AUSTRIA . 2019. [Oral Communication]

 

Reinisch, I; Gallè, B; Klymiuk, I; Karbiener, M; Galhuber, M; Krstic, J; Prokesch, A´ p53-driven miRNA-92a-5p expression as a potential regulator of BAT activity
Retrain the Brain, Doctoral Day 2018.. 2018; -DocDay; NOV 28, 2018; Graz, AUSTRIA . [Poster]

 

Leithner, K; Wohlkoenig, C; Stacher, E; Lindenmann, J; Ebner, B; Guelly, C; Smolle-Jüttner, FM; Popper, HH; Hrzenjak, A; Olschewski, A; Olschewski, H Neprilysin is induced by hypoxia and is a prognostic factor in non-small cell lung cancer
WIEN KLIN WOCHENSCHR. 2011; 123(17-18):A24-A24.-Jahrestagung der Österreichischen Gesellschaft für Pneumologie; SEPT 8-10, 2011; Vienna, AUSTRIA. [Oral Communication]
Web of Science

 

Nusshold, E; Senanayake, U; Guelly, C; Ebner, B; Leuschner, I; Hoefler, G; Guertl, B The role of Lim1 in renal development and renal neoplasms
Pannonia Congress of Pathology; MARCH 3-6; Graz, Austria. 2010. [Poster]

 

Augsten, M; Scharnagl, H; Gülly, C; Ebner, B; Chemelli, A; Glatter, O; Lang, U; Desoye, G; Wadsack, C HDL: A novel fetal signal regulating placental function.
Placenta2009; 30(9):-International Federation of Placenta Association, IFPA Meeting Placenta, the key to pregnancy success; Oct, 6-9, 2009; Adelaide, AUSTRALIA. [Poster]

 

Augsten, M; Scharnagl, H; Gülly, C; Ebner, B; Chemelli, A; Glatter, O; Mörtl, M; Lang, U; Desoye, G; Wadsack, C HDL:A novel fetal signal regulation placental functions.
Konferenzband ZMF2009; -Joint ZMF & Doctoral Days 2009; Nov, 2009; Graz, Austria. [Poster]

 

Glehr, M; Walzer, S; Lohberger, B; Rinner, B; Ebner, B; Gruber, G; Windhager, R Influence of Antioxidative Agents like Resveratrol, Quercetin-dihydrate, and Seleno-L-Methionine on Human Synoviocytes of Osteoarthritis (OA) and Rheumatoid Arthritis (RA).
ZMF Research Meeting; June 24, 2009; Graz, AUSTRIA. 2009. [Oral Communication]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
15. Austrian Ateriosclerosis Society Annual Meeting; 18. – 19. April 2008; St.Gilgen, Austria. 2008. [Oral Communication]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
2nd International Graz Symposium on Lipid and Membrane Biology: Focus on Lipotoxicity ; March 13-15; Graz, Austria. 2008. [Poster]

 

Buchebner, M; A. Kratzer, T.M. Becker, B. Ebner, N. Rathke, T. Pfeifer, S. Levak-Frank, G.M. Kostner and D. Kratky Synthetic LXR agonist attenuates plaque formation and reduces plasma triglycerides in apoE-deficient mice without inducing liver steatosis
14th ANNUAL SCANDINAVIAN ATHEROSCLEROSIS CONFERENCE; June 11-14, 2008; Humlebaek, Denmark. 2008. [Oral Communication]

 

Kratzer, A; Buchebner, M; Becker, TM; Pfeifer, T; Uray, G; Ebner, B; Rathke, N; Ahammer, H; Trauner, M; Hoefler, G; Levak-Frank, S; Levi, M; Kostner, GM; Kratky, D Partial LXR agonist reduces atherosclerosis in ApoE-deficient mice without inducing liver steatosis and hypertriglyceridemia
Experimental Biology 2008 (ASBMB); April 5-9, 2008; San Diego, USA. 2008. [Poster]

 

Kratzer, A; Buchebner M, Pfeifer T, Becker TM, Uray G, Miyazaki M, Miyazaki-Anzai S, Ebner B, Chandak PG, Kadam RS, Calayir E, Rathke N, Ahammer H, Radovic B, Trauner M, Hoefler G, Kompella UB, Fauler G, Levi M, Levak-Frank S, Kostner GM, Kratky D Synthetic LXR agonist reduces atherosclerotic plaque formation in ApoE deficient mice without inducing liver steatosis and hypertriglyceridemia
OEGBM meeting 22th to 24th September 2008, Graz, Austria; SEPT 22-24, 2008; Graz, AUSTRIA. 2008. [Oral Communication]

 

Kratzer, B; Ebner, T. Becker, E. Calayir, C. Guelly, M. Buchebner, T. Pfeifer, N. Rathke, S. Levak-Frank, N. Barry, T. Jiang, X. Wang, N. Zelcer, P. Tontonoz, M. Levi, G.M. Kostner, D. Kratky Novel Effects of Liver X Receptor (LXR) agonist N,N-Dimethyl-3â-hydroxycholenic acid (DMHCA) on the gene regulation and morphology of mouse peritoneal macrophages
Keystone symposium on nuclear receptors: orphan brothers and steroid sisters ; APRIL 30-May 4, 2008 ; Whistler, Canada. 2008. [Poster]

 

Ebner, B; Becker, T; Kratzer, A; Calayir, E; Buchebner, M; Trajanoski, Z; Gülly, C; Levak-Frank, S; Kostner; GM; Kratky, D Further characterization of MIG12, a novel gene involved in sterol and lipid metabolism
Gold Workshop 2007; 23-24.03.2007; Seggau, Austria. 2007. [Poster]

 

Effects of a Novel Liver X Receptor (LXR) Agonist on Murine Cholesterol and Lipid Metabolism Kratzer,A; Ebner,B; Becker,TM; Pfeifer,T; Calayir,E; Buchebner,M; Uray,G; Rechberger,G; Sattler,W; Lackner,K; Gülly,C; Levak-Frank,S; Kostner,GM and Kratky,D Effects of a Novel Liver X Receptor (LXR) Agonist on Murine Cholesterol and Lipid Metabolism
GOLD II meeting; MARCH 2007; SEGGAU. 2007. [Poster]

 

Kratzer, A; Ebner, B; Becker, TM; Pfeifer, T; Calayir, E; Buchebner, M; Uray, G; Rechberger, G; Sattler, W; Guelly, C; Levak-Frank, S; Kostner, GM; and Kratky, D Influences of a novel liver X receptor (LXR) agonist on cholesterol an lipid metabolism in murine macrophages and liver
Kern Aspen Lipid Conference; AUGUST 18-21, 2007; Aspen, CO, USA. 2007. [Poster]

 

Pfeifer, T; Becker, TM; Levak-Frank, S;Malli, R; Kratzer,A; Ebner,B; Kostner,GM; Kratky, D Localization of potential cholesteryl ester hydrolases (pCEH) in macrophages and liver cells.
14. Jahrestagung der Österreichischen Atherosklerosegesellschaft – AustrianAtherosclerosis Society (AAS); May 11-12, 2007; St.Gilden, Austria. 2007. [Oral Communication]

 

Becker, TM; Ebner, B; Kratzer, A; Buchebner, M; Calayir, E; Levak-Frank, S; Neuberger, G; Eisenhaber, F; Kostner, GM; Kratky, D Identification of lipolytic enzymes and their potential role in the cholesterol homeostasis of murine macrophages
Congress of the Austrian Atherosclerosis Society; May 5-6, 2006; St. Gilgen, Austria. 2006. [Oral Communication]

 

Becker, TM; Ebner, B; Kratzer, A; Calayir, E; Buchebner, M; Birner-Gruenberger, R; Hermetter, A; Levak-Frank, S; Kostner, GM; Kratky, D Identification of lipolytic enzymes and their potential role in the cholesterol homeostasis of murine macrophages
Annual Meeting of the Austrian Atherosclerosis Society; MAY 11-12, 2006; St. Gilgen, AUSTRIA. 2006. [Poster]

 

Calayir, E; Becker, TM; Ebner, B; Kratzer, A; Woelfler, G; Micutkova, L; Levak-Frank, S; Kratky, D; Kostner, GM Effects of LXR and PPARdelta ligands on the expression of genes involved in cholesterol metabolism in CaCo-2 cells
Congress of the Austrian Atherosclerosis Society; May 5-6, 2006; St. Gilgen, Austria. 2006. [Poster]

 

Ebner, B; Becker, T; Kratzer, H; Levak-Frank, S; Kostner, GM; Kratky, D Identification of differentially expressed genes with unknown function in murine macrophages and foam cells
13. Jahrestagung der Österreichischen Atherosklerosegesellschaft Austrian Atherosclerosis Society (AAS); 5-6 May 2006; St. Gilgen, Austria. 2006. [Poster]

 

Kratzer, A; Ebner, B; Becker, T; Calayir, E; Levak-Frank, S; Kostner, GM; Kratky, D Regulatory effects of a novel Liver X receptor (LXR) agonist
1st Graz Symposium on Lipid & Membrane Biology 2006; Graz; Austria; 16.-18.3.2006; Graz; Austria. 2006. [Poster]

 

Kratzer, A; Ebner, B; Becker, T; Calayir, E; Levak-Frank, S; Uray, G; Kostner, GM; Kratky, D Regulatory effects of a novel liver X receptor agonist.
joint meeting ELIFE and 47. International Conference on the Bioscience of Lipids (ICBL); 5.-9. September 2006; Pecs, Hungary. 2006. [Poster]

 

Kratzer, A; Ebner, B; Becker, T; Levak-Frank, S; Kostner, GM; Kratky, D Regulatory effects of a novel liver X receptor agonist.
13. Jahrestagung der Österreichischen Atherosklerosegesellschaft Austrian Atherosclerosis Society (AAS); 5-6 May 2006; St. Gilgen, Austria. 2006. [Poster]

 

Braun, J; Alten, R; Burmester, G; Grasedyck, K; Brandt, J; Haibel, H; Hammer, M; Krause, A; Mielke, F; Tony, H; Zeidler, H; Baumgartner, M; Beek, E; Ebner, B; Gomor, B; Hermann, J; Sieper, J Efficacy of sulfasalazine in undifferentiated spondyloarthritis and early ankylosing spondylitis - A multicenter randomized controlled trial.
ARTHRITIS RHEUM 2004 50: 4100-4100.
Web of Science

 

Ebner, B; Becker, T; Schittl, J; Kratzer, A; Levak-Frank, S; Kostner, G; Kratky, D Identification of novel genes in murine peritoneal macrophages and foam cells involved in cholesterol homeostasis
FASEB J 2004 18: C262-C262.
Web of Science

 

Kratzer, A; Ebner, B; Schittl, J; Becker, T; Levak-Frank, S; Kostner, G; Kratky, D Influence of nuclear receptor ligands on the cholesterol metabolism in RAW264.7 mouse macrophages and foam cells
FASEB J 2004 18: C262-C262.
Web of Science

 

© Med Uni Graz Impressum